'Ozempic Link to Rare Vision Loss Risk Confirmed in Study; Risk of Eye Condition Remains Low; Patients Should Be Aware; NAION Occurs When Loss of Blood Flow Damages Optic Nerve' - Bloomberg News
'Ozempic Link to Rare Vision Loss Risk Confirmed in Study; Risk of Eye Condition Remains Low; Patients Should Be Aware; NAION Occurs When Loss of Blood Flow Damages Optic Nerve' - Bloomberg News
Novo Nordisk A/S's blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that backs up Harvard University research published earlier this year.
諾和諾德公司（Novo Nordisk A/S）的爆款藥物Ozempic在一項研究中與一種罕見的視力損失風險增加相關，這項研究支持了哈佛大學在今年早些時候發佈的研究結果。
Diabetes patients who used Ozempic were more than twice as likely to be diagnosed with the rare condition, called NAION, than those who took another type of diabetes drug, according to a team of researchers who studied years of patient records from Denmark and Norway. The study wasn't able to determine whether there was a similar impact among people taking Ozempic's sister drug, Wegovy, for obesity.
根據一組研究人員對丹麥和挪威多年患者記錄的研究，使用Ozempic的糖尿病患者被診斷爲罕見疾病NAION的可能性是其他類型糖尿病藥物患者的兩倍以上。該研究未能判斷使用Ozempic的姐妹藥物Wegovy治療肥胖的人是否也有類似的影響。
譯文內容由第三人軟體翻譯。
